首页> 中文期刊> 《世界核心医学期刊文摘:妇产科学分册》 >宫颈癌患者染色体1杂合性缺失的临床病理学意义

宫颈癌患者染色体1杂合性缺失的临床病理学意义

         

摘要

We studied the loss of heterozygosity (LOH) in chromosome 1 in squamous cell carcinoma (SCC) of the uterine cervix and evaluated its clinical and pathological significance. Sixty- three highly polymorphic markers were used to study the LOH in 84 SCC. Microdissection was performed to enrich the tumor cells population before the alleotyping study. The findings were correlated with clinicopathologic findings. LOH was detected in all but one SCC. The number of loci showing LOH in each case ranged from 0 to 41. Five loci showed LOH in ≥ 30% SCC and 28 other loci had an LOH frequency between 20% and 30% . Six of the eight markers located at 1p36.21 to 1p36.33 had a frequency of LOH >20% . Shortened total survival was associated with LOH at 14 loci and shortened disease- free survival was associated with LOH at 11 loci while LOH at nine loci were associated with both. A high frequency of LOH was associated with stage as well as shortened total and disease- free survival. LOH is a common and early event in the development of cervical SCC. Tumor suppressor genes may be present at 1p36. The incidence of LOH increases as the tumor progresses but a high frequency of LOH is not an independent prognostic factor.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号